The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001239358
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
20/09/2026
Date registered
Help: Date registered
13/10/2026
Date last updated
Help: Date last updated
13/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
13/10/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Beyond Diagnosis: Immediate Human Immunodeficiency Virus (HIV) Peer Navigation Following HIV Diagnosis
Scientific title
A randomised controlled feasibility study of immediate referral to HIV Peer Navigation following HIV diagnosis and its impact on quality of life among people newly diagnosed with HIV
Additional trial identifiers [1] 318483 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Newly diagnosed HIV infection 343663 0
Condition category
Condition code
Infection 339780 339780 0 0
Acquired immune deficiency syndrome (AIDS / HIV)
Public Health 339876 339876 0 0
Health service research

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
What is the intervention?
Immediate referral to an HIV Peer Navigator following HIV diagnosis, in addition to standard HIV clinical care. The intervention provides peer-based emotional, practical and service-navigation support for people newly diagnosed with HIV. Emotional support may include sharing lived experience, addressing concerns, and supporting adjustment to an HIV diagnosis. Practical support may include information on treatment, adherence, disclosure, and stigma. Service-navigation support may include linking individuals to HIV care, support services, and relevant community resources.

Who delivers it and their relevant expertise?
HIV Peer Navigators employed by Queensland Positive People. Peer Navigators are people living with HIV trained to provide peer support and navigation services to people newly diagnosed with HIV.

How is it delivered?
Individual one-to-one peer support.

How often and for how long?
Support commences immediately following referral and is available throughout the 6 month study period. Frequency of contact is tailored to participant needs.

Where is it delivered?
Through Queensland Positive People in conjunction with recruitment from Metro North Sexual Health and HIV Services. Support may be delivered in clinical, community, telephone or online settings according to routine service practice.

Adherence
Participant engagement is monitored through the peer navigation referral process and monthly study follow-up. Survey reminders are used to support retention.
Intervention code [1] 335389 0
Treatment: Other
Description of the comparator or control
What is the comparator?
Standard HIV clinical care following diagnosis, including provision of clinical information, referral to HIV specialist care, initiation and monitoring of antiretroviral therapy, and routine follow-up. No immediate referral to an HIV Peer Navigator is provided as part of the study intervention.

Who delivers it and their relevant expertise?
Clinical staff at Metro North Sexual Health and HIV Services, including medical practitioners and nurses experienced in HIV care.

How is it delivered?
Individual clinical care delivered according to routine practice.

How often and for how long?
As required under routine HIV clinical management during the study period.

Where is it delivered?
Metro North Sexual Health and HIV Services.

Adherence
Attendance at routine clinical appointments and completion of monthly study surveys are monitored by the study team. Survey reminders are provided.
Control group
Active

Outcomes
Primary outcome [1] 346945 0
Change in quality of life over time between intervention and control groups
Timepoint [1] 346945 0
Baseline and then, monthly for six months following enrolment
Secondary outcome [1] 468212 0
Participant experiences of HIV Peer Navigation
Timepoint [1] 468212 0
3 months post-enrolment and 6 months post-enrolment
Secondary outcome [2] 468213 0
Feasibility and acceptability of immediate HIV Peer Navigation referral will be assessed as a composite secondary outcome. Feasibility and acceptability of immediate HIV Peer Navigator referral will be explored together through semi-structured interviews with participants and providers, together with peer navigator reflective field notes. Data will be analysed using thematic analysis informed by Normalisation Process Theory to identify barriers, enablers, experiences, and perceptions relating to implementation and uptake of immediate peer navigation referral.
Timepoint [2] 468213 0
Semi-structured interviews with health professionals and peer navigators will be conducted at 3 months and 6 months (end of the study period). Peer navigators will complete reflective field notes throughout the 6-month implementation period.

Eligibility
Key inclusion criteria
Participants must:
• Be aged 18 years or older
• Have received a new HIV diagnosis within the previous four weeks
• Have sufficient English language proficiency to provide informed consent
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants requiring immediate peer navigation support and for whom randomisation could cause harm, including those experiencing:
• Severe mental illness
• Homelessness or insecure housing
• Current domestic violence
• Hazardous alcohol or other drug use
• Repeated missed appointments or inability to engage with care

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central computer-based randomisation via the study recruitment portal. Allocation is concealed until participant enrolment and assignment.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated random sequence with 1:1 allocation to intervention or control groups.
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
This is a feasibility pilot randomised controlled trial. A formal power calculation was not conducted. The target sample size of 24 participants (12 intervention, 12 control) was selected based on the anticipated number of newly diagnosed people with HIV attending the study site during the recruitment period and to assess the feasibility, acceptability and implementation of immediate HIV Peer Navigation referral.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 323058 0
Commercial sector/Industry
Name [1] 323058 0
Gilead Sciences Investigator-Funded Community-Based Research Grant Scheme
Country [1] 323058 0
United States of America
Primary sponsor type
Other
Name
National Association of People with HIV Australia (NAPWHA)
Address
Country
Australia
Secondary sponsor category [1] 326008 0
None
Name [1] 326008 0
Address [1] 326008 0
Country [1] 326008 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321460 0
Metro North Health Human Research Ethics Committee
Ethics committee address [1] 321460 0
Ethics committee country [1] 321460 0
Australia
Date submitted for ethics approval [1] 321460 0
22/06/2026
Approval date [1] 321460 0
24/08/2026
Ethics approval number [1] 321460 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 153798 0
Mx Daniel Reeders
Address 153798 0
National Association of People with HIV Australia (NAPWHA): Ste G5/1 Erskineville Rd, Newtown NSW 2042
Country 153798 0
Australia
Phone 153798 0
+61422296018
Fax 153798 0
Email 153798 0
Contact person for public queries
Name 153799 0
Daniel Reeders
Address 153799 0
National Association of People with HIV Australia (NAPWHA): Ste G5/1 Erskineville Rd, Newtown NSW 2042
Country 153799 0
Australia
Phone 153799 0
+61422296018
Fax 153799 0
Email 153799 0
Contact person for scientific queries
Name 153800 0
Daniel Reeders
Address 153800 0
National Association of People with HIV Australia (NAPWHA): Ste G5/1 Erskineville Rd, Newtown NSW 2042
Country 153800 0
Australia
Phone 153800 0
+61422296018
Fax 153800 0
Email 153800 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Due to the small sample size and sensitive nature of HIV-related data, individual participant data will not be shared to minimise the risk of participant re-identification.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.